| Mathias James Lillig, MD | |
|
1001 N Minneapolis St, Wichita, KS 67214-3127 | |
| (316) 293-2647 | |
| (855) 476-0305 |
| Full Name | Mathias James Lillig |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 1001 N Minneapolis St, Wichita, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235344433 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 04-37527 (Kansas) | Primary |
| Entity Name | The Board Of Trustees Of The University Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609822147 PECOS PAC ID: 3072422716 Enrollment ID: O20031201000230 |
News Archive
Walking away from the federal commitment to Medicaid doesn't solve the problem; it just passes health care costs down to states. Because almost every state, including Maryland, is required by law to balance its budget every year, it means cuts in services and more financial strains for already suffering families, cuts in provider payments, lost jobs in the health care sector, and dampened business activity as the consequences of lost jobs and unmet health care needs ripple through the economy.
States are taking up the fight over the Obama administration's contraception coverage mandate with several state legislatures proposing bills of their own to block the mandate. In the meantime, Virginia mulls a bill that would require women to get a sonogram before an abortion, and a federal judge is set to rule on requiring pharmacists there to carry emergency contraception.
Response Biomedical Corporation announced today the signing of a subscription agreement providing for the sale of C$8 million of its common shares to funds affiliated with OrbiMed Advisors, LLC. The closing of the private placement is subject to receipt of all necessary regulatory approvals, including the approval of the Toronto Stock Exchange and the shareholders of the Company.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio's SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mathias James Lillig, MD Po Box 1358, Wichita, KS 67201-1358 Ph: (316) 293-3429 | Mathias James Lillig, MD 1001 N Minneapolis St, Wichita, KS 67214-3127 Ph: (316) 293-2647 |
News Archive
Walking away from the federal commitment to Medicaid doesn't solve the problem; it just passes health care costs down to states. Because almost every state, including Maryland, is required by law to balance its budget every year, it means cuts in services and more financial strains for already suffering families, cuts in provider payments, lost jobs in the health care sector, and dampened business activity as the consequences of lost jobs and unmet health care needs ripple through the economy.
States are taking up the fight over the Obama administration's contraception coverage mandate with several state legislatures proposing bills of their own to block the mandate. In the meantime, Virginia mulls a bill that would require women to get a sonogram before an abortion, and a federal judge is set to rule on requiring pharmacists there to carry emergency contraception.
Response Biomedical Corporation announced today the signing of a subscription agreement providing for the sale of C$8 million of its common shares to funds affiliated with OrbiMed Advisors, LLC. The closing of the private placement is subject to receipt of all necessary regulatory approvals, including the approval of the Toronto Stock Exchange and the shareholders of the Company.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio's SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.
› Verified 2 days ago
Javanthi Theegala, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1010 N Kansas St, Wichita, KS 67214 Phone: 316-293-2665 | |
Austin Armstrong, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1010 N Kansas St, Wichita, KS 67214 Phone: 316-293-2647 | |
Dr. Gilmar Costa, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1010 N Kansas St, Wichita, KS 67214 Phone: 316-293-2665 | |
Dr. Pete Haynes, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1010 N Kansas St, Wichita, KS 67214 Phone: 316-293-2665 | |
Mercedes J Perales, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9333 E 21st St N, Wichita, KS 67206 Phone: 316-634-4700 Fax: 316-634-4770 | |
Anthony Shaw, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1010 N Kansas St, Wichita, KS 67214 Phone: 316-293-2647 | |
Burtram J Odenheimer, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3311 E Murdock St, Wichita, KS 67208 Phone: 316-689-9137 Fax: 316-689-9659 |